Show simple item record

dc.contributor.authorBaldan, Vania
dc.contributor.authorGriffiths, R
dc.contributor.authorHawkins, Robert E
dc.contributor.authorGilham, David E
dc.date.accessioned2015-05-26T08:48:10Zen
dc.date.available2015-05-26T08:48:10Zen
dc.date.issued2015-04-28en
dc.identifier.citationEfficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma. 2015, 112 (9):1510-8 Br J Canceren
dc.identifier.issn1532-1827en
dc.identifier.pmid25867267en
dc.identifier.doi10.1038/bjc.2015.96en
dc.identifier.urihttp://hdl.handle.net/10541/555806en
dc.description.abstractTumour-infiltrating lymphocyte (TIL) therapy is showing great promise in the treatment of patients with advanced malignant melanoma. However, the translation of TIL therapy to non-melanoma tumours such as renal cell carcinoma has been less successful with a major constraint being the inability to reproducibly generate TILs from primary and metastatic tumour tissue.
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titleEfficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma.en
dc.typeArticleen
dc.contributor.department"Clinical and Experimental Immunotherapy Group, Institute of Cancer Sciences, University of Manchester, Manchester Academic Healthcare Science Centre, Paterson Building, Withington, Manchester M20 4BX, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractTumour-infiltrating lymphocyte (TIL) therapy is showing great promise in the treatment of patients with advanced malignant melanoma. However, the translation of TIL therapy to non-melanoma tumours such as renal cell carcinoma has been less successful with a major constraint being the inability to reproducibly generate TILs from primary and metastatic tumour tissue.


This item appears in the following Collection(s)

Show simple item record